Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice

Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis

(2019) Naofumi Yoshida et al.   CIRCULATION

Harms Reporting in Randomized Controlled Trials of Interventions Aimed at Modifying Microbiota

(2018) Aïda Bafeta et al.   ANNALS OF INTERNAL MEDICINE

Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers

(2017) Takayuki Kato et al.   PLoS One

Defecation frequency and cardiovascular disease mortality in Japan: The Ohsaki cohort study

(2016) Kenji Honkura et al.   ATHEROSCLEROSIS

B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation

(2016) Christopher Tay et al.   CARDIOVASCULAR RESEARCH

Akkermansia MuciniphilaProtects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation inApoe−/−MiceCLINICAL PERSPECTIVE

(2016) Jin Li et al.   CIRCULATION

Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut

(2016) Henrik M. Roager et al.   Nature Microbiology

Commensal Microbe-specific Activation of B2 Cell Subsets Contributes to Atherosclerosis Development Independently of Lipid Metabolism

(2016) Lin Chen et al.   EBioMedicine

Lubiprostone: a novel treatment for chronic constipation

(2016) Brian Lacy   Clinical Interventions in Aging

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed ch

(2014) Farrukh T. Awan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Artery Tertiary Lymphoid Organs Contribute to Innate and Adaptive Immune Responses in Advanced Mouse Atherosclerosis

(2014) Sarajo Kumar Mohanta et al.   CIRCULATION RESEARCH

Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD

(2014) E. Mishima et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria

(2013) Saswati Panda et al.   EMBO JOURNAL

Anti-interleukin-5 and multiple autoantibodies are associated with human atherosclerotic diseases and serum interleukin-5 levels

(2013) Tomoaki Ishigami et al.   FASEB JOURNAL

Characterization of Resident B Cells of Vascular Walls in Human Atherosclerotic Patients

(2013) M. Hamze et al.   JOURNAL OF IMMUNOLOGY

Lubiprostone stimulates small intestinal mucin release

(2012) Robert C De Lisle   BMC GASTROENTEROLOGY

Fecal Microbiota Composition Differs Between Children With  -Cell Autoimmunity and Those Without

(2012) M. C. de Goffau et al.   DIABETES

Gut microbiota, immune development and function

(2012) Stig Bengmark   PHARMACOLOGICAL RESEARCH

Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin

(2011) Prashant K. Nighot et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Gut permeability and food allergies

(2010) C. Perrier et al.   CLINICAL AND EXPERIMENTAL ALLERGY

B cell depletion reduces the development of atherosclerosis in mice

(2010) Hafid Ait-Oufella et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis

(2010) T. Kyaw et al.   JOURNAL OF IMMUNOLOGY

The intestinal barrier and its regulation by neuroimmune factors

(2010) å. v. Keita et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

(2009) Z. Gao et al.   DIABETES

Lymphotoxin β receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of agedApoE−/−mice

(2009) Rolf Gräbner et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Atherosclerosis—An immune disease

(2008) Göran K. Hansson   ATHEROSCLEROSIS

Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon

(2008) A K Bassil et al.   BRITISH JOURNAL OF PHARMACOLOGY

Comparison of the chloride channel activator lubiprostone and the oral laxative Polyethylene Glycol 3350 on mucosal barrier repair in ischemic-injured porcine intestine

(2008) Adam J Moeser et al.   WORLD JOURNAL OF GASTROENTEROLOGY